Overcoming antiestrogen resistance is, therefore, a priority for breast cancer researchers, and a number of factors have been implicated in endocrine resistance including EGFR [16] and HIF-1 [12, 13, 27]. The gene discussed is HIF1A; the disease is breast cancer.